tradingkey.logo
tradingkey.logo
Search

Briacell Therapeutics Corp

BCTX
Add to Watchlist
3.440USD
-0.190-5.23%
Close 07-31 16:00ETQuotes delayed by 15 min
29.92MMarket Cap
LossP/E TTM

BCTX Income Statement

You can find the annual or quarterly income statement of Briacell Therapeutics Corp here for insights into the performance and operational efficiency of Briacell Therapeutics Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
----
--225.67
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
20.42%7.62M
5.05%7.53M
61.52%8.32M
48.31%8.55M
-31.44%6.33M
-27.06%7.17M
-39.40%5.15M
-25.15%5.77M
62.58%9.23M
119.10%9.83M
57.37%8.50M
47.22%7.71M
37.68%5.68M
23.02%4.49M
136.48%5.40M
--5.23M
-14.22%4.12M
1817.90%3.65M
500.68%2.28M
849.08%4.81M
-86.68%190.15K
-67.45%380.37K
-60.18%512.57K
-53.11%506.45K
6.22%1.43M
18.37%1.17M
-12.72%1.29M
-3.50%1.08M
71.79%1.34M
91.18%987.10K
67.43%1.47M
26.57%1.12M
135.56%782.46K
55.26%516.34K
232.71%880.79K
243.40%884.32K
-57.93%332.17K
7.08%332.55K
-84.85%264.73K
-30.70%257.52K
8.72%789.62K
457.11%310.55K
894.11%1.75M
275.25%371.62K
736.39%726.26K
-31.79%55.74K
18.49%175.76K
-13.49%99.03K
-0.07%86.83K
-1.27%81.72K
667.08%148.33K
-7.72%114.48K
1222.03%86.89K
-44.42%82.77K
---26.16K
--124.05K
---7.74K
--148.91K
R&D expenses
24.04%5.97M
6.49%6.05M
82.35%6.68M
61.40%7.11M
-37.18%4.81M
-31.16%5.68M
-46.55%3.67M
-14.75%4.41M
98.36%7.66M
170.44%8.26M
110.65%6.86M
63.07%5.17M
70.16%3.86M
78.75%3.05M
271.75%3.26M
--3.17M
101.60%2.27M
931.56%1.71M
487.43%875.64K
448.89%1.13M
-82.08%165.59K
-80.19%149.06K
-64.66%349.18K
-74.16%205.03K
-20.93%924.21K
-1.30%752.51K
5.28%987.94K
51.26%793.37K
95.95%1.17M
103.82%762.41K
41.73%938.42K
-9.59%524.50K
270.08%596.49K
84.98%374.05K
2.57%662.12K
2824.79%580.13K
458.88%161.18K
519.01%202.21K
1857.02%645.54K
-9.37%19.84K
-51.46%28.84K
--32.67K
--32.99K
--21.89K
--59.41K
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
Depreciation, depletion, and amortization
23.84%33.01K
0.00%26.66K
0.00%26.66K
47.19%106.63K
598.53%26.66K
598.01%26.66K
598.19%26.66K
1797.43%72.44K
-0.05%3.82K
0.05%3.82K
0.00%3.82K
0.00%3.82K
0.00%3.82K
-0.03%3.82K
0.03%3.82K
--3.82K
0.10%3.82K
0.08%3.82K
0.08%3.82K
11.82%3.81K
7.14%3.81K
7.68%3.81K
-2.99%3.42K
--3.41K
1.18%3.56K
-78.62%3.54K
-72.78%3.53K
----
--3.52K
--16.57K
--12.96K
-100.00%0.00
-100.00%0.00
-100.00%0.00
----
--226.27
-5.46%220.43
-0.01%222.70
304.34%918.85
-100.00%0.00
--233.16
--222.73
-86.44%227.25
23.50%225.67
----
-100.00%0.00
754.88%1.68K
-8.07%182.72
-7.01%189.15
-4.87%194.79
-76.94%196.00
-77.12%198.76
-75.97%203.41
-76.29%204.77
--849.86
--868.78
--846.52
--863.69
Other operating expenses
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--60.22K
----
----
----
----
----
----
----
130.86%50.08K
---3.94K
84.34%-23.02K
---25.09K
---162.30K
--0.00
---146.97K
--0.00
Operating profit
-20.42%-7.62M
-5.05%-7.53M
-61.52%-8.32M
-48.31%-8.55M
31.44%-6.33M
27.06%-7.17M
39.40%-5.15M
25.15%-5.77M
-62.58%-9.23M
-119.10%-9.83M
-57.37%-8.50M
-47.22%-7.71M
-37.68%-5.68M
-23.02%-4.49M
-136.48%-5.40M
---5.23M
14.22%-4.12M
-1817.90%-3.65M
-500.68%-2.28M
-849.08%-4.81M
86.68%-190.15K
67.45%-380.37K
60.18%-512.57K
53.11%-506.45K
-6.22%-1.43M
-18.37%-1.17M
12.72%-1.29M
3.50%-1.08M
-71.79%-1.34M
-91.18%-987.10K
-67.43%-1.47M
-26.57%-1.12M
-135.56%-782.46K
-55.26%-516.34K
-232.71%-880.79K
-243.40%-884.32K
57.93%-332.17K
-7.08%-332.55K
84.85%-264.73K
30.70%-257.52K
-8.72%-789.62K
-457.11%-310.55K
-894.11%-1.75M
-275.25%-371.62K
-736.39%-726.26K
31.79%-55.74K
-18.49%-175.76K
13.49%-99.03K
0.07%-86.83K
1.27%-81.72K
-667.08%-148.33K
7.72%-114.48K
-1222.03%-86.89K
44.42%-82.77K
--26.16K
---124.05K
--7.74K
---148.91K
Net non-operating interest income (expenses)
Non-operating interest income
723.15%219.22K
125.57%105.64K
271.51%48.48K
1672100.00%33.44K
70.65%26.63K
-42.60%46.83K
-93.16%13.05K
-100.00%2.00
-93.84%15.61K
-66.09%81.59K
1.31%190.81K
153.50%208.78K
604.39%253.49K
1891.52%240.59K
2887.36%188.35K
--82.36K
--35.99K
--12.08K
--6.30K
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%3.01
--505.55
1083.21%5.27K
-31.53%3.31K
18458.28%181.06K
----
-83.41%445.20
6505.93%4.84K
12.92%975.64
374.68%1.10K
920.43%2.68K
-96.73%73.22
-88.34%864.03
-93.53%231.85
-76.54%263.04
--2.24K
299.62%7.41K
27.03%3.58K
-69.78%1.12K
-100.00%0.00
-89.03%1.85K
-35.89%2.82K
215.24%3.71K
-37.15%3.86K
149.38%16.90K
-67.27%4.40K
-62.05%1.18K
-58.10%6.14K
--6.78K
--13.44K
--3.10K
--14.65K
Non-operating interest expense
-19.87%29.63K
----
----
--0.00
--36.98K
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
-93.77%979.00
1633.69%62.42K
1424.45%45.79K
822.02%15.72K
389.88%18.32K
49.59%3.60K
-59.40%3.00K
-83.30%1.71K
-76.07%3.74K
--2.41K
--7.40K
--10.21K
--15.63K
----
----
----
----
----
----
----
----
----
----
----
--4.64K
----
----
----
----
----
----
----
--11.35K
----
----
----
----
----
----
----
Gains from sale of securities
-5612.82%-32.25K
-202.55%-21.05K
1647.68%20.68K
-269.52%-44.72K
124.47%585.00
62100.00%20.53K
87.85%-1.34K
10.26%-12.10K
78.88%-2.39K
100.51%33.00
-15.32%-10.99K
45.95%-13.48K
-5066.23%-11.32K
-8.13%-6.53K
-28138.24%-9.53K
---24.95K
100.03%228.00
---6.04K
--34.00
-1928950.24%-884.54K
100.00%0.00
100.00%0.00
125.41%1.62K
-99.85%45.86
---252.32
---14.94K
72.14%-6.40K
888.14%29.97K
-100.00%0.00
100.00%0.00
-11.95%-22.95K
-45.09%-3.80K
-47.55%9.80K
45.10%-1.37K
40.92%-20.50K
95.95%-2.62K
-70.14%18.68K
-225.30%-2.50K
-184.41%-34.71K
-1939.11%-64.65K
2559.00%62.58K
449.55%1.99K
--41.12K
---3.17K
--2.35K
100.48%362.96
100.00%0.00
--0.00
--0.00
---75.58K
---5.52K
----
----
----
----
----
----
----
Return on equity
-2.49%-64.30K
-45.58%-61.99K
37.31%-44.83K
7.41%-47.38K
-69.58%-62.74K
-132.13%-42.58K
---71.52K
---51.17K
---37.00K
---18.34K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
65.34%290.70K
-73.75%211.78K
103.29%20.29K
-90.21%448.81K
-98.39%175.83K
151.47%806.84K
-104.32%-616.64K
-10.00%4.58M
1929.13%10.95M
79.45%-1.57M
246.84%14.28M
7.73%5.09M
109.10%539.43K
-151.55%-7.63M
116.31%4.12M
--4.73M
-168.12%-5.93M
--14.80M
-99979.40%-25.25M
--8.70M
--0.00
57.80%-25.23K
-0.37%20.91K
100.00%0.00
-100.00%0.00
-131.49%-59.80K
106.71%20.98K
---47.62K
--156.79K
--189.89K
---312.84K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-7853.47%-7.72M
---438.12K
----
----
74.71%-97.03K
100.00%0.00
----
----
---383.62K
---259.18K
----
----
- Gains from disposal of fixed assets
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
-100.00%0.00
--904.55
--0.00
100.00%0.00
--144.20K
--0.00
--0.00
---3.13K
----
----
----
--0.00
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
213.65%1.40M
----
---1.50M
----
--447.89K
----
----
----
--0.00
----
----
----
----
----
----
----
Income before tax
-16.26%-7.24M
-15.13%-7.30M
-42.01%-8.28M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
678.35%2.95M
83.51%-235.93K
66.15%-421.33K
60.17%-508.35K
53.62%-510.01K
-20.31%-1.43M
-54.81%-1.24M
22.42%-1.28M
15.48%-1.10M
-54.04%-1.19M
-56.79%-804.11K
-82.72%-1.65M
-46.87%-1.30M
-148.46%-772.21K
-53.11%-512.87K
-201.54%-900.32K
-175.16%-885.84K
57.24%-310.80K
-9.36%-334.98K
0.01%-298.57K
13.27%-321.94K
67.32%-726.78K
-453.11%-306.32K
95.99%-298.60K
30.41%-371.20K
-2575.39%-2.22M
63.91%-55.38K
-7259.65%-7.44M
-384.58%-533.43K
3.02%-83.12K
-92.39%-153.44K
71.16%-101.14K
70.23%-110.08K
-890.28%-85.71K
40.59%-79.76K
---350.69K
---369.79K
--10.85K
---134.26K
Income tax
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--147.55K
--0.00
--0.00
--0.00
Income after tax
-16.26%-7.24M
-15.13%-7.30M
-42.01%-8.28M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
678.35%2.95M
83.51%-235.93K
66.15%-421.33K
60.17%-508.35K
53.62%-510.01K
-20.31%-1.43M
-54.81%-1.24M
22.42%-1.28M
15.48%-1.10M
-54.04%-1.19M
-56.79%-804.11K
-82.72%-1.65M
-46.87%-1.30M
-148.46%-772.21K
-53.11%-512.87K
-201.54%-900.32K
-175.16%-885.84K
57.24%-310.80K
-9.36%-334.98K
0.01%-298.57K
13.27%-321.94K
67.32%-726.78K
-453.11%-306.32K
95.99%-298.60K
30.41%-371.20K
-2575.39%-2.22M
63.91%-55.38K
-7259.65%-7.44M
-384.58%-533.43K
3.02%-83.12K
-92.39%-153.44K
79.70%-101.14K
70.23%-110.08K
-890.28%-85.71K
40.59%-79.76K
---498.23K
---369.79K
--10.85K
---134.26K
Net income from continuous operations
-16.26%-7.24M
-15.13%-7.30M
-42.01%-8.28M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
678.35%2.95M
83.51%-235.93K
66.15%-421.33K
60.17%-508.35K
53.62%-510.01K
-20.31%-1.43M
-54.81%-1.24M
22.42%-1.28M
15.48%-1.10M
-54.04%-1.19M
-56.79%-804.11K
-82.72%-1.65M
-46.87%-1.30M
-148.46%-772.21K
-53.11%-512.87K
-201.54%-900.32K
-175.16%-885.84K
57.24%-310.80K
-9.36%-334.98K
0.01%-298.57K
13.27%-321.94K
67.32%-726.78K
-453.11%-306.32K
95.99%-298.60K
30.41%-371.20K
-2575.39%-2.22M
63.91%-55.38K
-7259.65%-7.44M
-384.58%-533.43K
3.02%-83.12K
-92.39%-153.44K
79.70%-101.14K
70.23%-110.08K
-890.28%-85.71K
40.59%-79.76K
---498.23K
---369.79K
--10.85K
---134.26K
Net Income attributable to non-controlling interests
25.99%-72.55K
-61.77%-75.07K
-198.01%-80.76K
-110.30%-72.74K
-316.83%-98.03K
-18.07%-46.41K
36.49%-27.10K
---34.59K
---23.52K
---39.31K
---42.67K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-16.94%-7.16M
-14.79%-7.22M
-41.28%-8.20M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.80M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6.00M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
678.35%2.95M
83.51%-235.93K
66.15%-421.33K
60.17%-508.35K
53.62%-510.01K
-20.31%-1.43M
-54.81%-1.24M
22.42%-1.28M
15.48%-1.10M
-54.04%-1.19M
-56.79%-804.11K
-82.72%-1.65M
-46.87%-1.30M
-148.46%-772.21K
-53.11%-512.87K
-201.54%-900.32K
-175.16%-885.84K
57.24%-310.80K
-9.36%-334.98K
0.01%-298.57K
13.27%-321.94K
67.32%-726.78K
-453.11%-306.32K
95.99%-298.60K
30.41%-371.20K
-2575.39%-2.22M
63.91%-55.38K
-7259.65%-7.44M
-384.58%-533.43K
3.02%-83.12K
-92.39%-153.44K
79.70%-101.14K
70.23%-110.08K
-890.28%-85.71K
40.59%-79.76K
---498.23K
---369.79K
--10.85K
---134.26K
Net income attributable to common shareholders
-16.94%-7.16M
-14.79%-7.22M
-41.28%-8.20M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.80M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
642.37%6.00M
-437.06%-2.42M
51.12%-4.90M
-206.46%-11.88M
95.98%-1.11M
---450.35K
-439.55%-10.02M
4830.35%11.16M
-6434.94%-27.53M
678.35%2.95M
83.51%-235.93K
66.15%-421.33K
60.17%-508.35K
53.62%-510.01K
-20.31%-1.43M
-54.81%-1.24M
22.42%-1.28M
15.48%-1.10M
-54.04%-1.19M
-56.79%-804.11K
-82.72%-1.65M
-46.87%-1.30M
-148.46%-772.21K
-53.11%-512.87K
-201.54%-900.32K
-175.16%-885.84K
57.24%-310.80K
-9.36%-334.98K
0.01%-298.57K
13.27%-321.94K
67.32%-726.78K
-453.11%-306.32K
95.99%-298.60K
30.41%-371.20K
-2575.39%-2.22M
63.91%-55.38K
-7259.65%-7.44M
-384.58%-533.43K
3.02%-83.12K
-92.39%-153.44K
79.70%-101.14K
70.23%-110.08K
-890.28%-85.71K
40.59%-79.76K
---498.23K
---369.79K
--10.85K
---134.26K
Basic earnings per share
39.75%-0.99
-10.58%-2.58
-33.20%-4.35
-805.38%-9.23
-201.85%-1.64
78.02%-2.33
-158.00%-3.27
55.27%-1.02
134.03%1.61
7.70%-10.60
626.62%5.63
-423.36%-2.28
51.62%-4.73
-208.32%-11.49
96.05%-1.07
---0.44
-204.88%-9.78
331.28%10.60
-231.05%-27.10
188.02%9.33
84.58%-4.58
70.09%-8.19
64.23%-10.45
62.32%-10.60
9.36%-29.73
-21.43%-27.38
37.54%-29.20
39.56%-28.13
-5.96%-32.80
-8.44%-22.55
-22.96%-46.76
-19.95%-46.53
-121.22%-30.96
-27.27%-20.79
-159.20%-38.02
-128.04%-38.79
63.75%-13.99
-0.55%-16.34
6.86%-14.67
14.09%-17.01
77.05%-38.61
-247.12%-16.25
99.17%-15.75
85.40%-19.80
-698.72%-168.21
88.01%-4.68
-7294.29%-1.89K
-382.81%-135.57
3.36%-21.06
-92.09%-39.05
79.82%-25.59
70.23%-28.08
-884.21%-21.79
40.85%-20.33
---126.80
---94.33
--2.78
---34.37
Diluted earnings per share
39.75%-0.99
-10.58%-2.58
-33.20%-4.35
-805.38%-9.23
-201.85%-1.64
78.02%-2.33
-160.51%-3.27
55.27%-1.02
134.03%1.61
7.70%-10.60
604.71%5.40
-423.36%-2.28
51.62%-4.73
-226.27%-11.49
96.05%-1.07
---0.44
-204.88%-9.78
298.40%9.10
-231.05%-27.10
188.02%9.33
84.58%-4.58
70.09%-8.19
64.23%-10.45
62.32%-10.60
9.36%-29.73
-21.43%-27.38
37.54%-29.20
39.56%-28.13
-5.96%-32.80
-8.44%-22.55
-22.96%-46.76
-19.95%-46.53
-121.22%-30.96
-27.27%-20.79
-159.20%-38.02
-128.04%-38.79
63.75%-13.99
-0.55%-16.34
6.86%-14.67
14.09%-17.01
77.05%-38.61
-247.12%-16.25
99.17%-15.75
85.40%-19.80
-698.72%-168.21
88.01%-4.68
-7294.29%-1.89K
-382.81%-135.57
3.36%-21.06
-92.09%-39.05
79.82%-25.59
70.23%-28.08
-884.21%-21.79
40.85%-20.33
---126.80
---94.33
--2.78
---34.37
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Briacell Therapeutics Corp's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing BCTX stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Briacell Therapeutics Corp's net income for the year?

Briacell Therapeutics Corp posted -26.31M in net income for fiscal year 2025.

How much net income did Briacell Therapeutics Corp post in the last quarter?

Briacell Therapeutics Corp reported -7.16M in net income for the latest quarter。

What was Briacell Therapeutics Corp's annual operating profit?

Briacell Therapeutics Corp's operating income was -27.20M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.